{"prompt": "['11 July 2019', 'ARGX-113-1704', 'ARGX-113', 'Protocol Version 3.0, Final', 'Section', 'Change', 'Rationale', '6.8.1. Prohibited Medications', '-', '\"The following medications or', 'Wording added for', 'treatments will not be permitted as', 'clarification.', 'from signing the ICF during the trial:\"', 'changed to', '\"The following medications or', 'treatments will lead to discontinuation', 'from randomized treatment:\"', '-', '\"Rescue therapy\"', 'changed to', '\"Rescue therapy when used in patients', 'who meet the criteria to be rescued\"', '-', 'Additional bullet:', '\"Use of PLEX or immunoadsorption', 'more than once during study period\"', '6.8.2. Rescue Therapy', '-', 'First sentence (\"If necessary, patients', 'To be in line with the', 'may receive rescue therapy if their', 'corresponding section in the', 'gMG deteriorates.\") deleted.', 'Synopsis, Section 4.1, and', 'Section 6.8.1.', '-', 'The following sentence added at the', 'end of the section:', '\"In situations where the treatments as', 'listed above are given under the', 'protocol defined rescue criteria,', 'patients will be discontinued early from', 'randomized treatment.\"', '-', 'Last sentence (\"In situations where', 'rescue therapy is given, patients will be', 'discontinued early from randomized', 'treatment.\" deleted.', '6.11. Handling Missed Doses in', '\"In case a dose needs to be delayed for', 'Correction', 'the Investigational Medicinal', 'more than 5 days,', '\"', 'Product', 'changed to', '\"In case a dose needs to be delayed for', 'more than 3days,', '7.1.2. Quantitative Myasthenia', 'End of section, one but last sentence:', 'Updated because the rater', 'Gravis', '\"', 'dynamometer, and is based on', 'needs to be a trained person,', 'but not necessarily a', 'physician\\'s examination.\"', 'physician.', 'changed to', '\"', 'dynamometer, and is based on the', 'trained rater\\'s examination.\"', 'argenx BVBA', 'Confidential', 'Page 14 of 110']['11 July 2019', 'ARGX-113-1704', 'ARGX-113', 'Protocol Version 3.0, Final', 'Section', 'Change', 'Rationale', '7.1.3. Myasthenia Gravis', 'First sentence:', 'Updated because the rater', 'Composite', 'needs to be a trained person,', '\"The MGC has 10 items (Appendix 3)', 'but not necessarily a', 'combining physician examination and', 'physician.', 'patient reported outcomes.\"', 'changed to', '\"The MGC has 10 items (Appendix 3)', \"combining a trained rater's examination\", 'and patient reported outcomes.\"', '7.2.1.3. Follow-up of Adverse', '-', 'Second paragraph:', 'Table deleted and text', 'Events and Serious Adverse', '\"Every effort should be made to follow', 'updated to clarify that all', 'Events', 'all AEs', '\"', 'SAEs are to be followed-up', 'changed to', 'until resolution.', '\"Every effort should be made to follow', 'all (S)AEs', '\"', '-', 'Table 3 deleted', '7.2.1.4.1 Pregnancies in Female', 'The following sentence has been added:', 'Added for completeness.', 'Patients', '\"If required by local regulations, the', 'female participant will be requested to sign', 'a separate pregnancy ICF.\"', '7.3. Pharmacokinetics', '\"(PK)\" was added to the section title.', 'Added for completeness.', '7.4. Pharmacodynamics', '\"(PD)\" was added to the section title.', 'Added for completeness.', '7.5. Anti-Drug Antibodies', '\"(ADA)\" was added to the section title.', 'Added for completeness.', 'Second sentence:', 'Added for completeness', '(3-step analysis).', '\"At Baseline (SEB and TCnB),', 'confirmatory and titer analysis will be', 'performed using a validated ADA assay.\"', 'changed to', '\"At Baseline (SEB and TC1B), Screening,', 'confirmatory and titer analysis will be', 'performed using a validated ADA assay.\"', '8.4.3. Tertiairy Endpoint', '-', 'Last paragraph:', 'Correction (ARGX-113 is to', 'Analyses', '\"', 'using individual concentration data', 'be measured in serum and', 'in plasma and actual sampling times:\"', 'not in plasma).', 'changed to', '\"', 'using individual concentration data', 'in serum and actual sampling times:\"', '\"Cmax: maximum observed plasma', 'concentration\"', 'changed to', '\"Cmax: maximum observed serum', 'concentration\"', 'argenx BVBA', 'Confidential', 'Page 15 of 110']\n\n###\n\n", "completion": "END"}